[HTML][HTML] Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
[引用][C] Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer Chemotherapy …, 2019 - cir.nii.ac.jp
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer …, 2019 - europepmc.org
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
[PDF][PDF] Aspects of vincristine‑induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer Chemotherapy …, 2019 - core.ac.uk
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær… - Cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
[HTML][HTML] Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer …, 2019 - ncbi.nlm.nih.gov
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer Chemotherapy …, 2019 - vbn.aau.dk
PURPOSE: Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær… - Cancer …, 2019 - search.proquest.com
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review.
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer …, 2019 - europepmc.org
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
[PDF][PDF] Aspects of vincristine‑induced neuropathy in hematologic malignancies: a systematic review
ML Madsen, H Due, N Ejskjær, P Jensen… - Cancer Chemotherapy …, 2019 - vbn.aau.dk
Purpose Vincristine is widely used as anticancer therapy for a variety of hematological
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …
malignancies. The treatment is limited by progressive vincristine-induced neuropathy …